FDA Letter Warns About the Limitations of Antibody Tests for COVID-19
21 Apr, 2020 | 08:08h | UTCCommentary: FDA Warns Providers About Limits of SARS-CoV-2 Antibody Tests – NEJM Journal Watch
Commentary: FDA Warns Providers About Limits of SARS-CoV-2 Antibody Tests – NEJM Journal Watch